Biofrontera

Biofrontera Inc. is a U.S.-based biopharmaceutical company specializing in dermatology, with a focus on PDT. The company commercializes the drug-device combination of Ameluz® with the RhodoLED® lamp series for PDT treatment of actinic keratosis (AK), a precancerous skin condition that can develop into invasive skin cancer. The company conducts clinical trials to expand the use of its products for treating non-melanoma skin cancer and moderate to severe acne.